Clinical Trials Browser

Phase 3 × Hematopoietic and Lymphatic System Neoplasm × Bupropion × Clear all

NCT03996265 2026-01-15

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Phase 3 Active not recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm